BIO

Farah Lamiable-Oulaidi is leading the Carbohydrate chemistry group at Ferrier Research Institute. Her group aims to develop innovative therapeutics for rare diseases with unmet medical needs, specifically focusing on lysosomal storage disorders.

Farah studied Chemistry at the University of Orléans (France) and earned her PhD in Organic Chemistry at the ICOA-University of Orléans, conducting research on pharmacological chaperones for the treatment of Gaucher Disease in the laboratory of Professors Olivier Martin and Philippe Compain. 

After a postdoc in the laboratory of Dr Martina Lahmann at Bangor University (United Kingdom), she joined the Ferrier Research Institute to work with Professor Peter Tyler on the design and synthesis of enzyme transition-state analogue inhibitors. Dr Lamiable-Oulaidi remains closely involved in the research programs of Professors Tyler and Vern Schramm (Albert Einstein College of Medicine, New York).




ACADEMIC POSITIONS

  • Senior scientist
    Victoria University of Wellington, Ferrier Research Institute, Wellington, New Zealand1 Jan 2023 - present
  • Scientist
    Victoria University of Wellington, Wellington, Ferrier Research Institute, 69 Gracefield road, Wellington, lower Hutt, 5010, New Zealand11 May 2017 - present

DEGREES

  • PhD
    University of Orléans, Orléans, Orléans, France1 Oct 2007 - 28 Jan 2011

LANGUAGES

  • English
    Can read, write, speak, understand and peer review
  • French
    Can read, write, speak, understand and peer review

AVAILABILITY

  • Masters Research or PhD student supervision
  • Collaborative projects
  • Industry Projects

FIELDS OF RESEARCH